UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Gastroenterology (New York, N.Y. 1943), 2013-10, Vol.145 (4), p.782-789.e4

2013

Volltextzugriff (PDF)

Non alcoholic fatty liver: epidemiology and natural history

Reviews on recent clinical trials, 2015-01, Vol.9 (3), p.126-133

2015

Volltextzugriff (PDF)

Diagnosis and management of secondary causes of steatohepatitis

Journal of hepatology, 2021-06, Vol.74 (6), p.1455-1471

2021

Volltextzugriff (PDF)

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Journal of hepatology, 2023-12, Vol.79 (6), p.1542-1556

2023

Volltextzugriff (PDF)

De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose

Biological reviews of the Cambridge Philosophical Society, 2016-05, Vol.91 (2), p.452-468

2016

Volltextzugriff (PDF)

MAFLD: How is it different from NAFLD?

Clinical and Molecular Hepatology, 2023, 29(0), , pp.17-31

2023

Volltextzugriff (PDF)

Animal models of non‐alcoholic fatty liver disease: current perspectives and recent advances

The Journal of pathology, 2017-01, Vol.241 (1), p.36-44

2017

Volltextzugriff (PDF)

Rising Inpatient Encounters and Economic Burden for Patients with Nonalcoholic Fatty Liver Disease in the USA

Digestive diseases and sciences, 2019-03, Vol.64 (3), p.698-707

2019

Volltextzugriff (PDF)

Lessons on Drug Development: A Literature Review of Challenges Faced in Nonalcoholic Fatty Liver Disease (NAFLD) Clinical Trials

International journal of molecular sciences, 2022-12, Vol.24 (1), p.158

2022

Volltextzugriff (PDF)

Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish

Journal of hepatology, 2019-04, Vol.70 (4), p.710-721

2019

Volltextzugriff (PDF)

Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease

Journal of hepatology, 2023-04, Vol.78 (4), p.693-703

2023

Volltextzugriff (PDF)

Patients With Autoimmune Hepatitis and Nonalcoholic Fatty Liver Disease: Characteristics, Treatment, and Outcomes

Journal of clinical gastroenterology, 2024-01, Vol.58 (1), p.91-97

2024

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

Journal of hepatology, 2016-09, Vol.65 (3), p.589-600

2016

Volltextzugriff (PDF)

Global burden of liver disease: 2023 update

Journal of hepatology, 2023-08, Vol.79 (2), p.516-537

2023

Volltextzugriff (PDF)

Autophagy in liver diseases: A review

Molecular aspects of medicine, 2021-12, Vol.82, p.100973-100973, Article 100973

2021

Volltextzugriff (PDF)

Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD

Digestive and liver disease, 2021-09, Vol.53 (9), p.1154-1158

2021

Volltextzugriff (PDF)

Therapies in non‐alcoholic steatohepatitis (NASH)

Liver international, 2017-01, Vol.37 (S1), p.97-103

2017

Volltextzugriff (PDF)

Pro-Inflammatory Adipokine and Cytokine Profiles in the Saliva of Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)-A Pilot Study

International journal of molecular sciences, 2023-02, Vol.24 (3), p.2891

2023

Volltextzugriff (PDF)

Gut microbiota composition associated with hepatic fibrosis in non‐obese patients with non‐alcoholic fatty liver disease

Journal of gastroenterology and hepatology, 2021-08, Vol.36 (8), p.2275-2284

2021

Volltextzugriff (PDF)

Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases

Annual review of pathology, 2019-01, Vol.14 (1), p.153-184

2019

Volltextzugriff (PDF)

Molecular aspects of fructose metabolism and metabolic disease

Cell metabolism, 2021-12, Vol.33 (12), p.2329-2354

2021

Volltextzugriff (PDF)

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)

Endocrine practice, 2022-05, Vol.28 (5), p.528-562

2022

Volltextzugriff (PDF)

Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease

Gastroenterology (New York, N.Y. 1943), 2020-10, Vol.159 (4), p.1471-1486.e12

2020

Volltextzugriff (PDF)

1 – 25 von 3.925

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.800)
Mit Volltextzugriff
(3.516)

Publikationsform

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.721)
Life Sciences & Biomedicine
(3.692)
Nafld
(3.192)
Humans
(3.160)
Male
(1.730)
Animals
(1.518)
Fatty Liver
(1.311)
Liver Diseases
(1.305)
Female
(1.252)
Liver
(1.062)
Gastroenterology & Hepatology
(948)
Liver - Metabolism
(916)
Middle Aged
(869)
Non-Alcoholic Fatty Liver Disease
(861)
Nash
(855)
Non-Alcoholic Fatty Liver Disease - Metabolism
(848)
Mice
(829)
Adult
(825)
Obesity
(793)
Insulin Resistance
(766)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Non alcoholic fatty liver: epidemiology and natural history

Diagnosis and management of secondary causes of steatohepatitis

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose

MAFLD: How is it different from NAFLD?

Animal models of non‐alcoholic fatty liver disease: current perspectives and recent advances

Rising Inpatient Encounters and Economic Burden for Patients with Nonalcoholic Fatty Liver Disease in the USA

Lessons on Drug Development: A Literature Review of Challenges Faced in Nonalcoholic Fatty Liver Disease (NAFLD) Clinical Trials

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish

Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease

Patients With Autoimmune Hepatitis and Nonalcoholic Fatty Liver Disease: Characteristics, Treatment, and Outcomes

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

Global burden of liver disease: 2023 update

Autophagy in liver diseases: A review

Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD

Therapies in non‐alcoholic steatohepatitis (NASH)

Pro-Inflammatory Adipokine and Cytokine Profiles in the Saliva of Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)-A Pilot Study

Gut microbiota composition associated with hepatic fibrosis in non‐obese patients with non‐alcoholic fatty liver disease

Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases

Molecular aspects of fructose metabolism and metabolic disease

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)

Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease

Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches

Aktive Filter

Suchergebnisse filtern